Formerly CB1 Botanicals, CF Biotech is developing small molecule inhibitors, targeting the HSP90 protein complex, chemokines/CXCL10, NLRP3 and immune checkpoint proteins PD-L1/2. Funded by the Irish and Maltese governments (€1.2m) to address unmet clinical needs in ovarian cancer, neurodegenerative disorders and chronic inflammation, CF Biotech's vision is to enter Phase I trials in 2024.
Company Details
- Founded
- -
- Address
- Foxhole Business Park, Youghal,ireland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cb1botanicals.com
- Keywords
- São Paulo.
- HQ
- Cork, Munster
Cf Bio Questions
Cf Bio's website is http://www.cb1botanicals.com
Cf Bio's LinkedIn profile is https://ie.linkedin.com/company/cb1botancialscbd
Cf Bio's industry is
Biotechnology Research
Cf Bio's categories are Biotechnology Research
Cf Bio's founding year is 2017
